Daewoong pharmaceutical

069620.KO

91.84 USD

-0.44

-0.48%

Overview

Last close

91.84 usd

Market cap

1.06B usd

52 week high

119.37 usd

52 week low

69.54 usd

Target price

140.83 usd

Valuation

P/E

N/A

Forward P/E

N/A

Price/Sales

1.0618

Price/Book Value

1.8174

Enterprise Value

1.40B usd

EV/Revenue

1.389

EV/EBITDA

11.8391

Key financials

Revenue TTM

997.61M usd

Gross Profit TTM

455.00M usd

EBITDA TTM

124.84M usd

Earnings per Share

N/A usd

Dividend

N/A usd

Total assets

1,877.36B usd

Net debt

N/A usd

About

Daewoong Pharmaceutical Co., Ltd. manufactures and sells pharmaceutical products in South Korea and internationally. It offers products in therapeutic areas, such as central nervous system, endocrinology, musculoskeletal, nephrology, antineoplastic, cardiovascular, gastrointestinal, metabolic, antiviral, analgesic, antacid, and digestive diseases, as well as wound, iron supplements, and muti-vitamins. The company also provides COVID-19 PCR kit, COVID-19 IgG/IgM RDT, and viral transport medium medical devices. The company was founded in 1945 and is headquartered in Seoul, South Korea.